Valuation: Lonza Group AG

Market Cap 42.19B 51.2B 45.51B 38.38B 72.43B 4,860B 73.59B 507B 199B 2,536B 192B 188B 8,084B P/E 2026 *
35.3x
P/E 2027 * 29.5x
Enterprise Value 44.63B 54.16B 48.15B 40.6B 76.62B 5,141B 77.85B 536B 210B 2,683B 203B 199B 8,552B EV / Sales 2026 *
6.27x
EV / Sales 2027 * 5.63x
Free-Float
99.36%
Yield 2026 *
0.92%
Yield 2027 * 1.06%

Last Transcript: Lonza Group AG

1 day+0.03%
1 week+5.56%
Current month+5.01%
1 month+12.18%
3 months+5.01%
6 months+13.62%
Current year+12.31%
1 week 564
Extreme 564
608.4
1 month 543.8
Extreme 543.8
608.4
Current year 454.6
Extreme 454.6
608.4
1 year 454.6
Extreme 454.6
608.4
3 years 308.6
Extreme 308.6
616
5 years 308.6
Extreme 308.6
779.4
10 years 156.2
Extreme 156.2
785.4
Manager TitleAgeSince
Chief Executive Officer 54 2024-06-30
Director of Finance/CFO 54 2021-11-30
Chief Operating Officer - 2025-09-30
Director TitleAgeSince
Director/Board Member 67 2016-04-25
Director/Board Member 66 2018-05-03
Director/Board Member 60 2022-05-04
Date Insider Type Main position Quantity % Market Cap. Importance
5/8/26 Buy 460 0.0007%
5/8/26 Buy 618 0.0009%
3/11/26 Sell 179 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+0.03%+5.56%+10.18%+41.75% 50.83B
-6.60%-8.56%+42.79%+64.16% 68.98B
-4.09%-0.11%+2.31%+54.81% 53.15B
-1.53%+2.70%+29.72%+34.13% 44.61B
-1.34%+4.12%+16.05%+112.18% 42.53B
-5.97%-6.22%+258.21%+421.57% 40.57B
+6.53%+8.02%+15.74%+53.94% 30.95B
-0.90%-10.49%+31.48%-1.63% 25.44B
-2.76%-9.54%-16.53%-9.55% 22.66B
-1.07%+2.33%+17.24%+11.20% 22.65B
Average -1.77%+0.39%+40.72%+78.26% 40.24B
Weighted average by Cap. -2.35%+0.32%+43.19%+85.80%

Financials

2026 *2027 *
Net sales 7.12B 8.64B 7.68B 6.48B 12.23B 820B 12.42B 85.6B 33.56B 428B 32.44B 31.75B 1,365B 7.93B 9.63B 8.56B 7.22B 13.62B 914B 13.84B 95.38B 37.4B 477B 36.14B 35.38B 1,521B
Net income 1.22B 1.48B 1.32B 1.11B 2.09B 140B 2.13B 14.65B 5.74B 73.28B 5.55B 5.43B 234B 1.44B 1.74B 1.55B 1.31B 2.46B 165B 2.5B 17.25B 6.76B 86.28B 6.54B 6.4B 275B
Net Debt 2.44B 2.96B 2.63B 2.22B 4.19B 281B 4.26B 29.33B 11.5B 147B 11.11B 10.88B 468B 2.45B 2.97B 2.64B 2.23B 4.21B 282B 4.27B 29.46B 11.55B 147B 11.16B 10.93B 470B
Projected Income Statement - Annual - Lonza Group AG
Logo Lonza Group AG
Lonza Group AG is one of the world leaders of the contract development and manufacturing of pharmaceutical and biotechnology products. Net sales break down by family of products and services as follows: - biologics and bio-pharmaceuticals (55.9%): microbiological fermentation products, mammalian cell-based bio-pharmaceuticals, monoclonal antibodies, therapeutic proteins, etc.; - synthesis products (24.7%): chemopharmaceutical products, bioconjugates, small molecules, active pharmaceutical ingredients, complex intermediates, etc.; - specialised therapeutic products (15.8%): cell and gene therapies, synthetic therapeutic nucleic acids, oligonucleotides, microbial biological products, etc.; - others (3.6%).
Employees
20,141
Date Price Change Volume
26-10-16 CHF 604.00 +0.03% 170,304
26-10-15 CHF 603.80 +3.14% 225,545
26-10-14 CHF 585.40 +3.35% 224,750
26-10-13 CHF 566.40 -1.32% 117,576
26-10-12 CHF 574.00 +0.31% 57,521
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Lonza Group AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
604.00CHF
Average target price
693.04CHF
Spread / Average Target
+14.74%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Lonza Group AG
  1. Stock Market
  2. Stocks
  3. LONN Stock